Cargando…

Experimental Models for Aging and their Potential for Novel Drug Discovery

BACKGROUND: An interesting area of scientific research is the development of potential antiaging drugs. In order to pursue this goal, it is necessary to gather the specific knowledge about the adequate preclinical models that are available to evaluate the beneficial effects of new potential drugs. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Folch, Jaume, Busquets, Oriol, Ettcheto, Miren, Sánchez-López, Elena, Pallàs, Mercè, Beas-Zarate, Carlos, Marin, Miguel, Casadesus, Gemma, Olloquequi, Jordi, Auladell, Carme, Camins, Antoni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295931/
https://www.ncbi.nlm.nih.gov/pubmed/28685671
http://dx.doi.org/10.2174/1570159X15666170707155345
_version_ 1783380943695773696
author Folch, Jaume
Busquets, Oriol
Ettcheto, Miren
Sánchez-López, Elena
Pallàs, Mercè
Beas-Zarate, Carlos
Marin, Miguel
Casadesus, Gemma
Olloquequi, Jordi
Auladell, Carme
Camins, Antoni
author_facet Folch, Jaume
Busquets, Oriol
Ettcheto, Miren
Sánchez-López, Elena
Pallàs, Mercè
Beas-Zarate, Carlos
Marin, Miguel
Casadesus, Gemma
Olloquequi, Jordi
Auladell, Carme
Camins, Antoni
author_sort Folch, Jaume
collection PubMed
description BACKGROUND: An interesting area of scientific research is the development of potential antiaging drugs. In order to pursue this goal, it is necessary to gather the specific knowledge about the adequate preclinical models that are available to evaluate the beneficial effects of new potential drugs. This review is focused on invertebrate and vertebrate preclinical models used to evaluate the efficacy of antiaging compounds, with the objective to extend life span and health span. METHODS: Research and online content related to aging, antiaging drugs, experimental aging models is reviewed. Moreover, in this review, the main experimental preclinical models of organisms that have contributed to the research in the pharmacol-ogy of lifespan extension and the understanding of the aging process are discussed. RESULTS: Dietary restriction (DR) constitutes a common experimental process to extend life span in all organisms. Besides, classical antiaging drugs such as resveratrol, rapamycin and metformin denominated as DR mimetics are also discussed. Likewise, the main therapeutic targets of these drugs include sirtuins, IGF-1, and mTOR, all of them being modulated by DR. CONCLUSION: Advances in molecular biology have uncovered the potential molecular pathways involved in the aging process. Due to their characteristics, invertebrate models are mainly used for drug screening. The National Institute on Aging (NIA) developed the Interventions Testing Program (ITP). At the pre-clinical level, the ITP uses Heterogeneous mouse model (HET) which is probably the most suitable rodent model to study potential drugs against aging prevention. The accelerated-senescence mouse P8 is also a mammalian rodent model for aging research. However, when evaluating the effect of drugs on a preclinical level, the evaluation must be done in non-human primates since it is the mammalian specie closest to humans. Research is needed to investigate the impact of new potential drugs for the increase of human quality of
format Online
Article
Text
id pubmed-6295931
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-62959312019-06-01 Experimental Models for Aging and their Potential for Novel Drug Discovery Folch, Jaume Busquets, Oriol Ettcheto, Miren Sánchez-López, Elena Pallàs, Mercè Beas-Zarate, Carlos Marin, Miguel Casadesus, Gemma Olloquequi, Jordi Auladell, Carme Camins, Antoni Curr Neuropharmacol Article BACKGROUND: An interesting area of scientific research is the development of potential antiaging drugs. In order to pursue this goal, it is necessary to gather the specific knowledge about the adequate preclinical models that are available to evaluate the beneficial effects of new potential drugs. This review is focused on invertebrate and vertebrate preclinical models used to evaluate the efficacy of antiaging compounds, with the objective to extend life span and health span. METHODS: Research and online content related to aging, antiaging drugs, experimental aging models is reviewed. Moreover, in this review, the main experimental preclinical models of organisms that have contributed to the research in the pharmacol-ogy of lifespan extension and the understanding of the aging process are discussed. RESULTS: Dietary restriction (DR) constitutes a common experimental process to extend life span in all organisms. Besides, classical antiaging drugs such as resveratrol, rapamycin and metformin denominated as DR mimetics are also discussed. Likewise, the main therapeutic targets of these drugs include sirtuins, IGF-1, and mTOR, all of them being modulated by DR. CONCLUSION: Advances in molecular biology have uncovered the potential molecular pathways involved in the aging process. Due to their characteristics, invertebrate models are mainly used for drug screening. The National Institute on Aging (NIA) developed the Interventions Testing Program (ITP). At the pre-clinical level, the ITP uses Heterogeneous mouse model (HET) which is probably the most suitable rodent model to study potential drugs against aging prevention. The accelerated-senescence mouse P8 is also a mammalian rodent model for aging research. However, when evaluating the effect of drugs on a preclinical level, the evaluation must be done in non-human primates since it is the mammalian specie closest to humans. Research is needed to investigate the impact of new potential drugs for the increase of human quality of Bentham Science Publishers 2018-12 2018-12 /pmc/articles/PMC6295931/ /pubmed/28685671 http://dx.doi.org/10.2174/1570159X15666170707155345 Text en © 2018 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Folch, Jaume
Busquets, Oriol
Ettcheto, Miren
Sánchez-López, Elena
Pallàs, Mercè
Beas-Zarate, Carlos
Marin, Miguel
Casadesus, Gemma
Olloquequi, Jordi
Auladell, Carme
Camins, Antoni
Experimental Models for Aging and their Potential for Novel Drug Discovery
title Experimental Models for Aging and their Potential for Novel Drug Discovery
title_full Experimental Models for Aging and their Potential for Novel Drug Discovery
title_fullStr Experimental Models for Aging and their Potential for Novel Drug Discovery
title_full_unstemmed Experimental Models for Aging and their Potential for Novel Drug Discovery
title_short Experimental Models for Aging and their Potential for Novel Drug Discovery
title_sort experimental models for aging and their potential for novel drug discovery
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295931/
https://www.ncbi.nlm.nih.gov/pubmed/28685671
http://dx.doi.org/10.2174/1570159X15666170707155345
work_keys_str_mv AT folchjaume experimentalmodelsforagingandtheirpotentialfornoveldrugdiscovery
AT busquetsoriol experimentalmodelsforagingandtheirpotentialfornoveldrugdiscovery
AT ettchetomiren experimentalmodelsforagingandtheirpotentialfornoveldrugdiscovery
AT sanchezlopezelena experimentalmodelsforagingandtheirpotentialfornoveldrugdiscovery
AT pallasmerce experimentalmodelsforagingandtheirpotentialfornoveldrugdiscovery
AT beaszaratecarlos experimentalmodelsforagingandtheirpotentialfornoveldrugdiscovery
AT marinmiguel experimentalmodelsforagingandtheirpotentialfornoveldrugdiscovery
AT casadesusgemma experimentalmodelsforagingandtheirpotentialfornoveldrugdiscovery
AT olloquequijordi experimentalmodelsforagingandtheirpotentialfornoveldrugdiscovery
AT auladellcarme experimentalmodelsforagingandtheirpotentialfornoveldrugdiscovery
AT caminsantoni experimentalmodelsforagingandtheirpotentialfornoveldrugdiscovery